Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Initiator Pharma A/S

INIT
Current price
7 SEK +0.49 SEK (+7.69%)
Last closed 6.75 SEK
ISIN DK0060775872
Sector Healthcare
Industry Biotechnology
Exchange Stockholm Exchange
Capitalization 403 182 541 SEK
Yield for 12 month -30.69 %
1Y
3Y
5Y
10Y
15Y
INIT
21.11.2021 - 28.11.2021

Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. Its product pipeline includes IPED2015, a drug candidate which is in clinical phase 2a for the treatment of organic erectile dysfunction; IP2018, a monoamine reuptake inhibitor completed Phase IIa for the treatment of psychogenic erectile dysfunction primarily targeting the serotonin followed by the dopamine system; and IPTN2021, a Phase 1 clinical drug program targeting an orphan drug indication in severe neuropathic pain, and trigeminal neuralgia. The company also developing IP2017, a proprietary triple reuptake inhibitor; and IP2016, a preclinical development for the treatment of depression. Initiator Pharma A/S was incorporated in 2016 and is headquartered in Copenhagen, Denmark. Address: Ole Maaloes vej 3, Copenhagen, Denmark, 2200

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

260.14 SEK

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-36 519 SEK

Last Year

-59 939 291 SEK

Current Quarter

-5 704 563 SEK

Last Quarter

-4 525 279 SEK

Key Figures INIT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -42 412 943 SEK
Operating Margin TTM
PE Ratio
Return On Assets TTM -43.56 %
PEG Ratio
Return On Equity TTM -72.71 %
Wall Street Target Price 260.14 SEK
Revenue TTM
Book Value 0.34 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM -38 314 960 SEK
Earnings per share -0.34 SEK
Diluted Eps TTM -0.34 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics INIT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History INIT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation INIT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 9.8135
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -6.1769
Price Book MRQ 13.7498

Financials INIT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators INIT

For 52 weeks

6.63 SEK 11.72 SEK
50 Day MA 7.45 SEK
Shares Short Prior Month
200 Day MA 8.55 SEK
Short Ratio
Shares Short
Short Percent